External link, please review our disclaimer.

About the National Institute on Drug Abuse SBIR/STTR Program

The National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) supports most of the world's research on the health aspects of drug abuse and addiction. NIDA-supported science addresses the most fundamental and essential questions about drug abuse, which range from the molecule to managed care and from DNA research to community outreach.

There are four major goals of the SBIR program:

  1. stimulate technological innovation;
  2. use small business to meet federal research and development needs;
  3. foster and encourage participation by minorities and disadvantaged persons in technological innovation; and
  4. increase private sector commercialization of innovations derived from federal R&D.

The goals of NIDA's SBIR/STTR programs focus on bridging the gap between performance of basic science and commercialization of resulting innovations. NIDA's research topics range from basic to clinical research, behavioral and prevention research, and science education. Applications are also encouraged for other areas of research.

Search for Funding

Featured Publication

Mentoring, A Guide for Drug Abuse Researchers publication cover

Mentoring: A Guide for Drug Abuse Researchers

Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site